Getting Mounjaro on the NHS: the real eligibility picture

You've been told you might qualify, here's what the NHS actually checks

Picture this: your GP mentions Mounjaro, or you've read about the NICE recommendation and you're wondering if this applies to you. The short answer is that NHS eligibility for Mounjaro is tied to a specific list of five qualifying conditions: high blood pressure, dyslipidaemia (raised cholesterol or triglycerides), obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes. It is not enough to have a high BMI alone.

For Cohort 1, which opened in June 2025, you need a BMI of 40 or above plus four of those five conditions simultaneously. Cohort 2, which activated in June 2026, lowers the BMI threshold to 35–39.9, but still requires four qualifying conditions. A third phase, expected around March 2027, will require a BMI of 40 or above plus three conditions. The NICE guidance for this is set out in NICE technology appraisal TA1026, published December 2024.

Meeting those numbers on paper is not a guarantee of access either. Every NHS patient must also be enrolled in a wraparound diet and physical activity support programme. If you want to understand the full process from assessment to prescription, our guide on how to get Mounjaro on the NHS walks through each step, including what to expect from your GP and what the structured programme involves. Availability varies by GP practice and area because GP participation in the new prescribing scheme (which opened from April 2026 under the updated QOF contract) is optional, not mandatory. Some practices are fully set up; others are not yet taking referrals.

What happens if you meet the criteria, and what happens if you don't

If your GP practice is participating and your figures align with the current cohort, you would typically be assessed and then prescribed Mounjaro on the NHS, with follow-up support through a structured programme. Treatment starts at 2.5mg (a starter dose designed to let your system adjust) and is titrated upward by a prescriber over weeks based on how you respond.

If you don't meet the NHS criteria, or your GP practice hasn't yet implemented the scheme, or you'd simply rather not wait, a private route is available. Getting Mounjaro privately through a regulated online pharmacy doesn't require a referral or a waiting list, it requires a clinical assessment with a prescriber who decides whether treatment is appropriate for you. The licensed private eligibility criteria are broader: adults with a BMI of 30 or above, or a BMI of 27 or above if you have at least one weight-related health condition. A prescriber reviews the whole picture, not just the numbers.

For a fuller breakdown of how the NHS rollout criteria compare phase by phase, the NHS Mounjaro overview sets it out clearly.

The honest cost context, and what private treatment includes

One practical question that comes up immediately is cost. On the NHS, Mounjaro is free at the point of care (standard prescription charge rules apply). Privately, prices vary by dose and provider. After Eli Lilly raised UK list prices from 1 September 2025, typical private monthly costs have ranged roughly £149–£375 depending on dose and where you go, figures that have been widely reported since the change. The full breakdown of what affects that price is worth reading before you compare services.

What those headline figures sometimes don't show is what's included. Some providers charge separately for the consultation, the prescription, and delivery. At nume, one transparent price covers all of that, consultation with a GPhC-registered prescriber, same-day clinical review, and free next-working-day delivery by DPD in plain packaging. There are no subscription commitments and no auto-renewals; every repeat order is clinically reviewed fresh.

The pen lives in the fridge between doses, typically on the same shelf as your weekend leftovers, there's no special equipment involved, and the routine settles quickly for most people.

Verifying any online pharmacy, and a note on fake pens

If you're considering the private route, using a pharmacy you can verify matters. Any legitimate UK online pharmacy dispensing a prescription-only medicine like Mounjaro must be registered with the GPhC. You can check the register directly at pharmacyregulation.org. The MHRA has warned repeatedly about counterfeit weight-loss pens sold through social media and unverified websites, including fake tirzepatide pens seized from an unlicensed site in 2025. A seller offering Mounjaro without requiring a clinical assessment is a red flag, report suspect sellers via the MHRA's Yellow Card scheme.

If you want to understand whether private treatment could suit you before committing, the eligibility comparison page shows how the NHS and private criteria differ side by side. And if you're ready to find out where you stand, speaking to our prescribers starts with a free consultation, no referral needed.